What is Pemetrexed?
Category: Prescription Drugs
Most popular types: Alimta
Pemetrexed is an anticancer drug used to treat malignant pleural mesothelioma and nonsquamous nonsmall cell lung cancer. It has also been used for bladder, cervical, ovarian cancer and thymic cancer.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 13 | 5 | |
| Lung cancer | 11 | 4 | |
| Pleural mesothelioma | 10 | 0 | |
| Mesothelioma of peritoneum | 2 | 0 | |
| Doctor recommendation | 1 | 1 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 2 | |
| Mild | 5 | |
| None | 1 |
Commonly reported side effects and conditions associated with Pemetrexed
| Side effect | Patients | Percentage |
|---|---|---|
| Chronic fatigue | 1 | |
| Cyclic vomiting syndrome | 1 | |
| Fatigue | 1 | |
| Itchy rash | 1 | |
| Large itchy welts | 1 | |
| Pressure headaches | 1 |
Why patients stopped taking Pemetrexed
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Course of treatment ended | 1 | |
| Doctor's advice | 1 |
Duration
Stopped taking Pemetrexed
| Duration | Patients | Percentage |
|---|---|---|
| 6 months - 1 year | 1 | |
| 1 - 2 years | 1 |
What people switch to and from
Patients started taking Pemetrexed after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Bevacizumab (Avastin) | 1 | |
| Chemotherapy | 1 | |
| Pemetrexed-carboplatin chemotherapy | 1 |
Patients stopped taking Pemetrexed and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Crizotinib (Xalkori) | 1 | |
| Etoposide (Toposar) | 1 | |
| Gefitinib (Iressa) | 1 | |
| Nivolumab (Opdivo) | 1 | |
| Paclitaxel (Taxol) | 1 |
Last updated: